In cases with PLEKHA5 and FRS2 rearrangements that were multi-sampled, the respective fusions were present in all investigated tumour materials (core needle biopsy, resection specimen, recurrence and/or metastasis), except for Case 12 (FRS2::ADAM32). Here, PLEKHA5 is linked to neoplasm.